GO:0006909 phagocytosis: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006909 phagocytosis is a vesicle-mediated transport process in which phagocytes engulf external particulate material and deliver it to lysosomes for digestion.
• Phagocytosis is central to innate immunity, tissue remodeling, synaptic pruning, and clearance of apoptotic cells and debris [1,2,5].
• Microglia and other glial cells use phagocytosis to eliminate synapses and debris in the central nervous system, linking the process to neurodegeneration [2,3,7].
• Dendritic cells exploit phagocytosis for antigen presentation, bridging innate and adaptive immunity.
• Dysregulated phagocytosis contributes to cancer progression, glioma immune evasion, and retinal degeneration [4,8].
• CRISPR knockout, knock-in, and overexpression models are essential for dissecting phagocytosis-related gene function and for therapeutic target discovery [1,4].
Description
Phagocytosis (GO:0006909) is an evolutionarily conserved biological process by which specialized cells called phagocytes recognize, engulf, and degrade external particulate material, including pathogens, apoptotic cells, and cellular debris. This process is fundamental to host defense, tissue homeostasis, and development, and its dysregulation is implicated in a broad spectrum of human diseases ranging from infections to neurodegeneration and cancer [1,5]. In the central nervous system, microglia and astrocytes perform phagocytic clearance of synapses and debris, a function that is critical for normal brain wiring and for preventing pathological accumulation of toxic material [2,3,7]. Dendritic cells utilize phagocytosis to capture antigens and present them to T cells, thereby initiating adaptive immune responses. Recent studies have further revealed that phagocytosis can actively induce cell death in target cells, a phenomenon termed cell death by phagocytosis, which has broad implications for cancer immunosurveillance and tissue turnover. Understanding the molecular machinery, regulatory checkpoints, and disease relevance of phagocytosis is therefore a high-priority research area. This article synthesizes authoritative QuickGO annotation data and verified PubMed literature to provide a research-grade overview of GO:0006909, its core components, key genes, experimental models, and CRISPR-based strategies for functional interrogation.
phagocytosis At A Glance
| GO ID | GO:0006909 |
|---|---|
| GO term | phagocytosis |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Engulfment of external particulate material and delivery to lysosomes for degradation |
| Cellular context | Phagocytes including macrophages, microglia, dendritic cells, and neutrophils [1,5,6] |
| Key subprocesses | Particle recognition, actin-driven engulfment, phagosome maturation, lysosomal fusion [1,3] |
| Disease relevance | Neurodegeneration, cancer, infections, retinal degeneration [1,4,7,8] |
What Is GO:0006909?
According to the Gene Ontology, GO:0006909 phagocytosis is defined as a vesicle-mediated transport process that results in the engulfment of external particulate material by phagocytes and their delivery to the lysosome. The particles are initially contained within phagocytic vacuoles called phagosomes, which subsequently fuse with primary lysosomes to effect digestion of the particles. In essence, phagocytosis is a specialized form of endocytosis dedicated to the uptake and degradation of large particles, distinguishing it from other vesicle trafficking pathways by its dependence on actin remodeling, phagocytic receptor engagement, and lysosomal fusion.
Why Is phagocytosis Important in Cell Biology?
Phagocytosis is a cornerstone of innate immunity and tissue homeostasis, and its dysfunction is directly linked to major human pathologies. It enables the clearance of invading pathogens and apoptotic cells, thereby preventing chronic inflammation and autoimmunity. In the brain, microglial and astrocytic phagocytosis shapes neural circuits by eliminating excess synapses and clearing debris, and impairments in this process contribute to neurodegenerative diseases [2,3,7]. In cancer, tumor-associated macrophages and glioma-associated microglia exhibit altered phagocytic activity that can either promote tumor progression or be harnessed for therapy. Moreover, photoreceptor outer segment phagocytosis by retinal pigment epithelium is essential for vision, and its disruption leads to retinal degeneration. Thus, understanding the molecular regulation of phagocytosis offers opportunities for therapeutic intervention across immunology, neuroscience, and oncology.
• Defends the host by engulfing and destroying pathogens.
• Clears apoptotic cells and cellular debris to maintain tissue homeostasis [1,3].
• Prunes synapses and refines neural circuits during development and in adulthood [2,7].
• Facilitates antigen presentation by dendritic cells, linking innate and adaptive immunity.
• Supports retinal health through daily phagocytosis of photoreceptor outer segments.
• Contributes to tumor microenvironment remodeling and immune evasion in gliomas.
• Mediates cell death by phagocytosis, a newly recognized form of programmed cell removal.
• Involves distinct microglial and monocyte populations with specialized phagocytic roles in the CNS.
• Is regulated by rhythmic and circadian mechanisms in the retina.
• Provides a target for modulating neuroinflammation and neurodegeneration [3,7].
What Happens During phagocytosis?
Particle Recognition and Receptor Engagement
In simple terms: The phagocyte first identifies the target particle by using special receptors that bind to markers on the particle surface.
Phagocytosis is initiated when phagocytic receptors on the surface of the phagocyte recognize and bind to ligands on the target particle. These ligands can be intrinsic to the particle, such as phosphatidylserine on apoptotic cells, or deposited by opsonins like antibodies and complement proteins. This receptor engagement triggers intracellular signaling cascades that activate actin polymerization and membrane remodeling. Different phagocytic receptors, including Fc receptors, complement receptors, and scavenger receptors, mediate distinct downstream responses and can influence the subsequent inflammatory or tolerogenic outcome [1,5]. In the central nervous system, microglia and astrocytes express a variety of phagocytic receptors that allow them to recognize synapses and debris [2,3,7].
Actin-Driven Engulfment and Phagosome Formation
In simple terms: The cell membrane wraps around the particle using a dynamic actin skeleton, trapping it inside a bubble called a phagosome.
Following receptor activation, localized actin polymerization drives the extension of pseudopods that surround the particle, leading to its internalization within a membrane-bound vacuole termed the phagosome. This step requires the coordinated activity of Rho-family GTPases, actin-nucleating proteins, and membrane trafficking regulators. The nascent phagosome then undergoes a maturation process involving sequential fusion and fission events with endosomal compartments, gradually acquiring the machinery needed for degradation [1,3]. In microglia, the actin cytoskeleton is dynamically remodeled during synaptic phagocytosis, and disruption of these dynamics impairs synapse elimination [2,7].
Phagosome Maturation and Lysosomal Fusion
In simple terms: The phagosome matures and fuses with lysosomes, which deliver digestive enzymes that break down the engulfed material.
After internalization, the phagosome matures through interactions with the endolysosomal system, ultimately fusing with lysosomes to form a phagolysosome. This fusion delivers hydrolytic enzymes and acidifies the lumen, leading to the degradation of the engulfed particle. The process is tightly regulated by Rab GTPases, SNARE proteins, and the HOPS complex. In astrocytes, clearance of microglial debris involves C4b-facilitated phagocytosis followed by RUBICON-dependent noncanonical autophagy for degradation, highlighting cell-type-specific maturation pathways. Defects in phagosome maturation can lead to accumulation of undigested material and chronic inflammation.
Antigen Presentation and Immune Modulation
In simple terms: After digestion, some phagocytes display pieces of the particle on their surface to activate other immune cells.
In dendritic cells and other professional antigen-presenting cells, phagocytosis is coupled to antigen processing and presentation. Peptides derived from the degraded cargo are loaded onto MHC molecules and displayed on the cell surface to activate T cells, thereby bridging innate and adaptive immunity. This process is essential for initiating immune responses against pathogens and for maintaining tolerance to self-antigens. The efficiency of antigen presentation can be influenced by the route of phagocytosis and the maturation state of the phagocyte.
Cell Death by Phagocytosis
In simple terms: In some cases, phagocytosis can actively kill the target cell, a process called cell death by phagocytosis.
Recent evidence has established that phagocytosis can directly induce the death of target cells, a phenomenon termed cell death by phagocytosis. This can occur when a living cell is engulfed by a phagocyte, leading to its demise. This mechanism has been implicated in developmental processes, tissue homeostasis, and cancer immunosurveillance. Understanding the molecular triggers and consequences of cell death by phagocytosis is an active area of research, with potential therapeutic implications for enhancing immune clearance of tumor cells.
Key Genes Involved in GO:0006909 phagocytosis
The following genes and proteins represent core components and regulators of phagocytosis, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MERTK | Receptor tyrosine kinase that recognizes phosphatidylserine on apoptotic cells | Mediates clearance of apoptotic cells; implicated in retinal degeneration |
| AXL | Receptor tyrosine kinase involved in efferocytosis and immune regulation | Modulates macrophage phagocytosis and tumor immune evasion |
| C1QA | Complement component that opsonizes targets for phagocytosis | Facilitates synaptic pruning and debris clearance |
| C3 | Central complement protein that promotes opsonization and phagocytosis | Links innate immunity to phagocytic clearance |
| CR3 (ITGAM/ITGB2) | Complement receptor 3 mediating phagocytosis of complement-coated particles | Key for pathogen clearance and microglial function |
| FCGR | Fc gamma receptors that bind antibody-coated targets | Drive antibody-dependent phagocytosis in macrophages |
| RAC1 | Rho GTPase regulating actin polymerization during engulfment | Essential for phagosome formation |
| CDC42 | Rho GTPase controlling actin dynamics and pseudopod extension | Required for efficient phagocytosis |
| RAB5 | Early endosomal GTPase involved in phagosome maturation | Regulates phagosome fusion events |
| RAB7 | Late endosomal GTPase required for phagolysosome formation | Critical for degradation of engulfed cargo |
| RUBICON | Regulator of noncanonical autophagy involved in degradation of phagocytosed debris | Mediates clearance of microglial debris in astrocytes |
| GAS6 | Ligand for MERTK/AXL that bridges phosphatidylserine to receptors | Promotes efferocytosis and tissue homeostasis |
| MFGE8 | Opsonin that links phosphatidylserine to integrin receptors | Facilitates apoptotic cell clearance |
| TREM2 | Immune receptor that regulates microglial phagocytosis | Associated with neurodegenerative disease risk |
| CD47 | Don't-eat-me signal that inhibits phagocytosis | Target for enhancing tumor cell phagocytosis |
| SIRPA | Receptor for CD47 that transmits inhibitory signals | Blocks phagocytosis of cancer cells |
| LC3 | Autophagy protein involved in LC3-associated phagocytosis | Links phagocytosis to autophagy machinery |
How Is phagocytosis Regulated?
Phagocytosis is regulated at multiple levels, including receptor signaling, actin dynamics, and transcriptional programs. In the retina, photoreceptor outer segment phagocytosis exhibits rhythmic diversity controlled by circadian clocks, ensuring daily renewal of visual pigments. In the central nervous system, microglial phagocytosis is modulated by neuronal activity, complement deposition, and immune receptors such as TREM2. In tumors, phagocytosis is often suppressed by CD47-SIRPα signaling, and therapeutic blockade of this axis enhances macrophage-mediated clearance of cancer cells. Additionally, the metabolic state of the phagocyte, including mTOR signaling and autophagy pathways, can influence phagocytic capacity and cargo degradation. These regulatory layers provide numerous entry points for experimental manipulation and therapeutic intervention.
phagocytosis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MERTK | Retinal degeneration (retinitis pigmentosa) | Knockout mouse or iPSC-derived RPE cells |
| CD47 | Cancer immune evasion | Tumor xenografts with CD47 knockout or overexpression |
| TREM2 | Neurodegeneration (Alzheimer's disease risk) | Knock-in mouse models with TREM2 variants |
| C1QA | Synaptic pruning defects and neurodegeneration | C1qa knockout mice |
| RUBICON | Impaired clearance of debris in astrocytes | Rubicon knockout mice |
Phagocytosis in Neurodegeneration
Microglial and astrocytic phagocytosis is essential for clearing debris and pruning synapses, but excessive or impaired phagocytosis contributes to neurodegeneration. In mouse models, astrocytes clear microglial debris via C4b-facilitated phagocytosis and degrade it through RUBICON-dependent noncanonical autophagy. Microglia act as hunters or gatherers of brain synapses, and their phagocytic activity is linked to synaptic loss in disease. Comparative studies of microglia and monocytes reveal distinct phagocytic behaviors that may differentially impact neurodegeneration. Targeting these pathways could modulate disease progression.
Phagocytosis in Cancer
Tumor-associated macrophages and microglia exhibit diverse phagocytic states that influence tumor progression. In malignant gliomas, differential phagocytosis induces diverse macrophage activation states, which can either promote or inhibit tumor growth. Cancer cells often evade phagocytosis by upregulating CD47, a don't-eat-me signal, and therapeutic blockade of CD47-SIRPα enhances phagocytic clearance. Cell death by phagocytosis represents a potential mechanism for eliminating tumor cells.
Phagocytosis in Retinal Degeneration
The retinal pigment epithelium performs daily phagocytosis of photoreceptor outer segments, a process essential for vision. This phagocytic activity is regulated by circadian rhythms, and its disruption leads to retinal degeneration. Defects in receptor tyrosine kinases such as MERTK cause retinitis pigmentosa, highlighting the critical role of phagocytosis in retinal health.
Phagocytosis in Infectious and Inflammatory Diseases
Phagocytosis is a primary defense against pathogens, and its impairment increases susceptibility to infections. Dendritic cell phagocytosis is coupled to antigen presentation, which is vital for adaptive immunity. Dysregulated phagocytosis can also contribute to chronic inflammatory diseases due to impaired clearance of apoptotic cells.
From phagocytosis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate phagocytosis of apoptotic cells? | CRISPR knockout in macrophage cell line (e.g., RAW264.7) |
| Does a point mutation in gene Y affect phagosome maturation? | Knock-in of mutant allele in primary microglia |
| Can overexpression of gene Z enhance tumor cell phagocytosis? | Overexpression in glioma-associated macrophages |
| What is the role of gene W in synaptic pruning? | Tagged knock-in in mouse brain for imaging |
| Does gene V control circadian phagocytosis in retina? | Knockout in retinal pigment epithelium |
| How does gene U affect antigen presentation after phagocytosis? | Knockout in dendritic cells |
How to Study the phagocytosis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Phagocytic uptake and phagosome maturation | Visualizing engulfment in macrophages |
| Flow cytometry | Percentage of phagocytosing cells and particle uptake | Quantifying phagocytosis in mixed populations |
| RNA-seq | Transcriptional changes during phagocytosis | Identifying activation states in glioma macrophages |
| Proteomics | Protein composition of phagosomes | Discovering novel phagosome components |
| CRISPR knockout | Loss-of-function effects on phagocytosis | Testing essential genes in cell lines |
| CRISPR knock-in | Effect of specific mutations on phagocytosis | Modeling disease-associated variants |
| Live-cell imaging | Dynamics of phagosome formation and maturation | Tracking synaptic pruning by microglia |
| Phagocytosis assay with pHrodo | Acidification of phagosomes | Measuring lysosomal fusion |
Imaging-Based Phagocytosis Assays
Fluorescence microscopy and live-cell imaging are widely used to visualize phagocytic uptake of fluorescently labeled particles, such as pHrodo-labeled zymosan or apoptotic cells. These methods allow quantification of engulfment efficiency, phagosome maturation, and lysosomal fusion in real time [1,3]. In the brain, two-photon imaging has been used to track microglial phagocytosis of synapses in vivo.
Flow Cytometry and Phagocytosis Quantification
Flow cytometry enables high-throughput quantification of phagocytosis by measuring the uptake of fluorescent particles or labeled targets at the single-cell level. It can be combined with surface marker staining to identify specific phagocyte populations, such as microglia versus monocytes. This approach is useful for screening genetic perturbations that affect phagocytic capacity.
Transcriptomic and Proteomic Profiling
RNA sequencing and proteomics can reveal global changes in gene expression and protein abundance associated with phagocytosis. For example, differential phagocytosis in gliomas induces diverse macrophage activation states that can be dissected by transcriptomics. These methods help identify novel regulators and pathways involved in phagocytic processes.
Genetic Perturbation with CRISPR
CRISPR-Cas9 knockout, knock-in, and overexpression models are powerful tools for dissecting the function of specific genes in phagocytosis. Knockout of candidate genes in macrophage or microglial cell lines can reveal essential roles in engulfment or degradation. Knock-in of disease-associated mutations allows study of their impact on phagocytic activity. Overexpression can test sufficiency of a gene to enhance phagocytosis.
How CRISPR Can Be Used to Study GO:0006909 phagocytosis
Knockout
CRISPR knockout is used to completely ablate candidate genes to determine their necessity in phagocytosis. For example, knocking out MERTK or RAC1 in macrophage cell lines impairs engulfment of apoptotic cells. Knockout models are also valuable for studying genes involved in phagosome maturation, such as RAB7.
Point Mutation
CRISPR point mutation introduces specific amino acid changes to model disease-associated variants or to dissect domain functions. For instance, knock-in of a kinase-dead mutation in MERTK can reveal the importance of its catalytic activity in retinal phagocytosis. This approach is precise and avoids confounding effects of complete gene loss.
Knock-in
CRISPR knock-in can be used to tag endogenous proteins with fluorescent markers or to insert reporter genes for tracking phagocytosis. Tagged knock-in of LC3 allows monitoring of LC3-associated phagocytosis in live cells. Knock-in of human disease alleles into mouse models facilitates translational research.
Overexpression
CRISPR activation or cDNA overexpression is used to test whether increased levels of a gene enhance phagocytosis. Overexpression of GAS6 or MFGE8 can boost efferocytosis in macrophages. In cancer research, overexpression of CD47 inhibits phagocytosis, and its knockdown enhances tumor cell clearance.
How EDITGENE Supports phagocytosis Research
Researchers studying phagocytosis-related genes often need to determine whether a candidate gene is causally involved in engulfment, phagosome maturation, or immune modulation. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation in relevant cell models, accelerating functional discovery and therapeutic development.
Contact EDITGENE today to design your custom CRISPR model for phagocytosis research.
Frequently Asked Questions About phagocytosis
What is phagocytosis GO:0006909?
Phagocytosis (GO:0006909) is a biological process in which phagocytes engulf external particulate material and deliver it to lysosomes for degradation.
What genes are involved in phagocytosis?
Key genes include MERTK, AXL, C1QA, C3, RAC1, CDC42, RAB5, RAB7, TREM2, and CD47, among others [1,3,4,7].
How is phagocytosis regulated?
Phagocytosis is regulated by receptor signaling, actin dynamics, circadian clocks, and immune checkpoints such as CD47-SIRPα [4,8].
What diseases are associated with defective phagocytosis?
Defective phagocytosis is linked to neurodegeneration, cancer, retinal degeneration, and chronic infections [1,3,4,8].
What is cell death by phagocytosis?
Cell death by phagocytosis is a process where a phagocyte engulfs a living cell, leading to its death, and is implicated in cancer immunosurveillance.
How do microglia perform phagocytosis?
Microglia use phagocytic receptors to recognize synapses and debris, followed by actin-driven engulfment and lysosomal degradation [2,7].
What is the role of astrocytes in phagocytosis?
Astrocytes can clear microglial debris via C4b-facilitated phagocytosis and degrade it through RUBICON-dependent noncanonical autophagy.
How can I study phagocytosis in the lab?
Common methods include fluorescence microscopy, flow cytometry, RNA-seq, proteomics, and CRISPR-based genetic perturbation [1,4,5].
What is the difference between phagocytosis and endocytosis?
Phagocytosis is a specialized form of endocytosis for large particles, requiring actin remodeling and phagosome formation.
What CRISPR models are available for phagocytosis research?
Knockout, point mutation, knock-in, and overexpression models can be generated in macrophage, microglial, or dendritic cell lines [1,3,4].
Conclusion
Phagocytosis (GO:0006909) is a fundamental biological process with critical roles in immunity, tissue homeostasis, and disease. The integration of QuickGO annotations with verified literature highlights the complexity of its regulation and the diverse cellular contexts in which it operates. Advances in CRISPR-based genetic models and high-throughput screening are accelerating the discovery of novel phagocytosis regulators and therapeutic targets. Continued research into the molecular mechanisms of phagocytosis promises to yield new strategies for treating cancer, neurodegeneration, and infectious diseases.
References
- 1. Brown GC. 2024. Cell death by phagocytosis.. Nat Rev Immunol 24(2):91-102 PMID: 37604896
- 2. Kono R et al.. 2023. [Synaptic phagocytosis by multiple glial cell types].. Nihon Yakurigaku Zasshi 158(5):348-352 PMID: 37673608
- 3. Zhou T et al.. 2022. Microglial debris is cleared by astrocytes via C4b-facilitated phagocytosis and degraded via RUBICON-dependent noncanonical autophagy in mice.. Nat Commun 13(1):6233 PMID: 36280666
- 4. Lakshmanachetty S et al.. 2025. Differential phagocytosis induces diverse macrophage activation states in malignant gliomas.. J Immunother Cancer 13(9) PMID: 40912739
- 5. Andoh M et al.. 2021. Comparative Review of Microglia and Monocytes in CNS Phagocytosis.. Cells 10(10) PMID: 34685535
- 6. Savina A et al.. 2007. Phagocytosis and antigen presentation in dendritic cells.. Immunol Rev 219:143-56 PMID: 17850487
- 7. Pereira-Iglesias M et al.. 2025. Microglia as hunters or gatherers of brain synapses.. Nat Neurosci 28(1):15-23 PMID: 39663381
- 8. Moran AL et al.. 2022. Regulation of the rhythmic diversity of daily photoreceptor outer segment phagocytosis in vivo.. FASEB J 36(10):e22556 PMID: 36165194
